An international randomised trial found fewer cases of acute kidney injury with cefazolin than with flucloxacillin or cloxacillin, while meeting its survival noninferiority threshold.
A Novartis oral pill for relapsing multiple sclerosis outperformed standard therapy in two large Phase III trials, and unlike a rival BTK inhibitor the FDA declined over liver concerns, it showed no liver safety signal. Here is what the REMODEL
UC Boulder researchers say a single injection reversed osteoarthritis in animal models in four to eight weeks. The ARPA-H-funded therapy is not yet peer-reviewed, but human clinical trials could start within 18
A University of Ottawa systematic review of five clinical trials found creatine improved depression outcomes in two studies targeting women with major depressive disorder but showed no benefit in three others. Safety
A JAMA Network Open study tracking 68 million patient records found ivermectin prescriptions among cancer patients more than doubled after Mel Gibson's Joe Rogan interview. The American Society of Clinical Oncology says
Casey Harrell, an ALS patient who lost the ability to speak, has communicated nearly two million words over two years using a brain-computer interface developed by the BrainGate 2 research team at
A London-based clinical trial has begun recruiting patients for POLB 001, an oral drug designed to prevent the cytokine storm that hospitalises a majority of cancer immunotherapy patients — with no approved
A growing controversy inside the U.S. public health establishment has erupted after reports that the Food and Drug Administration halted publication of multiple taxpayer-funded studies concluding that COVID-19 and shingles vaccines are
A new wave of research suggests arginine, an inexpensive and widely available compound, may reduce toxic protein buildup linked to Alzheimer’s disease, challenging long-held assumptions about dementia progression. For decades, Alzheimer’s science
The thymus, long regarded as a vestigial organ of early life, is now at the center of a decisive shift in biomedical science. After years of observational research linking thymic decline to
The US Food and Drug Administration has authorized an early access pathway for an experimental pancreatic cancer pill, daraxonrasib, developed by Revolution Medicines, marking a rare regulatory acceleration in one of oncology’s
RSV Vaccination During Pregnancy Reduces Infant Hospitalizations, New Global Evidence Shows Respiratory syncytial virus, widely recognized as respiratory syncytial virus (RSV), has long remained one of the most persistent drivers of infant
Follow